#CRISPR gene editing

[ follow ]
Nature
2 months ago
OMG science

'ChatGPT for CRISPR' creates new gene-editing tools

Researchers are now using generative AI to design CRISPR gene-editing systems, showing promising results in designing and testing new systems in the laboratory. [ more ]
Axios
6 months ago
Health

FDA approves CRISPR-based therapy for sickle cell disease

The FDA has approved the first therapy using CRISPR gene-editing technology to treat sickle cell disease.
The technology has the potential to be applied to other blood disorders, certain cancers, and infectious diseases. [ more ]
Axios
6 months ago
Health

FDA approves CRISPR-based therapy for sickle cell disease

The FDA has approved the first therapy using CRISPR gene-editing technology to treat sickle cell disease.
The technology has the potential to be applied to other blood disorders, certain cancers, and infectious diseases. [ more ]
Axios
6 months ago
Medicine

FDA approves CRISPR-based therapy for sickle cell disease

The FDA has approved the first therapy using CRISPR gene-editing technology to treat sickle cell disease.
The technology has the potential to be applied to other blood disorders, certain cancers, and infectious diseases. [ more ]
#Casgevy
www.scientificamerican.com
7 months ago
Health

U.K. Becomes First Country to Approve a CRISPR Disease Treatment

UK medicines regulator approves CRISPR gene editing therapy for sickle-cell disease and -thalassaemia.
Casgevy completely relieved 28 out of 29 participants of pain from sickle-cell disease for at least one year after treatment.
For at least one year after treatment with Casgevy, 93% of participants with a severe form of -thalassaemia did not need a red-blood-cell transfusion. [ more ]
www.scientificamerican.com
7 months ago
Health

U.K. Becomes First Country to Approve a CRISPR Disease Treatment

UK medicines regulator approves CRISPR gene editing therapy for sickle-cell disease and -thalassaemia.
Casgevy completely relieved 28 out of 29 participants of pain from sickle-cell disease for at least one year after treatment.
For at least one year after treatment with Casgevy, 93% of participants with a severe form of -thalassaemia did not need a red-blood-cell transfusion. [ more ]
www.scientificamerican.com
7 months ago
Health

U.K. Becomes First Country to Approve a CRISPR Disease Treatment

UK medicines regulator approves CRISPR gene editing therapy for sickle-cell disease and -thalassaemia.
Casgevy completely relieved 28 out of 29 participants of pain from sickle-cell disease for at least one year after treatment.
For at least one year after treatment with Casgevy, 93% of participants with a severe form of -thalassaemia did not need a red-blood-cell transfusion. [ more ]
www.scientificamerican.com
7 months ago
Health

U.K. Becomes First Country to Approve a CRISPR Disease Treatment

UK medicines regulator approves CRISPR gene editing therapy for sickle-cell disease and -thalassaemia.
Casgevy completely relieved 28 out of 29 participants of pain from sickle-cell disease for at least one year after treatment.
For at least one year after treatment with Casgevy, 93% of participants with a severe form of -thalassaemia did not need a red-blood-cell transfusion. [ more ]
moreCasgevy
[ Load more ]